The headquarters of Kindeva Drug Delivery in Woodbury traded hands for $48.2 million this week. Austin, Texas-based Virtus Real Estate Capital sold the property to an entity that lists an email ...
ST. LOUIS and WOODBURY, Minn., March 31, 2025 /PRNewswire/ -- Kindeva, a global CDMO and drug delivery expert, has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its ...
Kindeva Drug Delivery and Emervax have partnered to co-develop a vaccine delivery solution for a range of viruses. The partnership gives Emervax an exclusive licence to use Kindeva’s solid-coated ...
The Food and Drug Administration has given tentative approval to Viatris and Kindeva Drug Delivery for their Symbicort generic (budesonide/formoterol fumarate ...
23RD MARCH 2026: Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a breakthrough therapy that ...
Kindeva Drug Delivery, a 3M spinoff company, is establishing its new global headquarters in Woodbury with help from an array of state funding sources. The company, which provides drug delivery ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Kindeva Drug Delivery L.P. (Kindeva) and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus ...
LOUGHBOROUGH, England, WOODBURY, Minn., and ST. LOUIS; June 4, 2024 (Business Wire) – Leading global drug-device combination product CDMO Kindeva Drug Delivery (Kindeva) today announced the expansion ...
ST. PAUL, Minn. & ST. LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (“Kindeva”) and Meridian Medical Technologies (“Meridian”) announced today the completion of the transaction to combine the two ...
Kindeva, a CDMO focused on drug delivery devices, hauled in a 33 million pound sterling ($42.1 million) grant from the U.K.’s Life Sciences Innovation Manufacturing Fund that will be used to bolster ...
"At a time of significant transformation and growth, having a strong financial leader is critical to our success. Dan's extensive expertise in corporate finance, investor relations, and strategic ...